Cargando…
Contemporary trends and barriers to oral anticoagulation therapy in Non-valvular atrial fibrillation during DOAC predominant era
There is a need to reassess contemporary oral anticoagulation (OAC) trends and barriers against guideline directed therapy in the United States. Most previous studies were performed before major guideline changes recommended direct oral anticoagulant (DOAC) use over warfarin or have otherwise lacked...
Autores principales: | Sehrawat, Ojasav, Kashou, Anthony H., Van Houten, Holly K., Cohen, Ken, Joe Henk, Henry, Gersh, Bernard J., Abraham, Neena S., Graff-Radford, Jonathan, Friedman, Paul A., Siontis, Konstantinos C., Noseworthy, Peter A., Yao, Xiaoxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164915/ https://www.ncbi.nlm.nih.gov/pubmed/37168417 http://dx.doi.org/10.1016/j.ijcha.2023.101212 |
Ejemplares similares
-
Percutaneous Left Atrial Appendage Occlusion in Comparison to Non‐Vitamin K Antagonist Oral Anticoagulant Among Patients With Atrial Fibrillation
por: Noseworthy, Peter A., et al.
Publicado: (2022) -
Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation
por: Noseworthy, Peter A., et al.
Publicado: (2015) -
Anticoagulation for Stroke Prevention in Older Adults with Atrial Fibrillation and Comorbidity: Current Evidence and Treatment Challenges
por: Sabbag, Avi, et al.
Publicado: (2018) -
Laboratory Monitoring of Direct Oral Anticoagulants (DOACs)
por: Dunois, Claire
Publicado: (2021) -
New Direct Oral Anticoagulants (DOAC) and Their Use Today
por: Schwarb, Heike, et al.
Publicado: (2016)